MRI evaluation of microvascular obstruction in experimental reperfused acute myocardial infarction using a T1 and T2 preparation pulse sequence

Journal of Magnetic Resonance Imaging

Volumn 26, Issue 6, 2007, Pages 1486-1492

  Yang, Yuesong ^a,c   Foltz, Warren D ^b   Graham, John J ^a   Detsky, Jay S ^a   Dick, Alexander J ^a   Wright, Graham A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Contrast enhanced MRI; Microvascular obstruction; No reflow; Relaxometry; Reperfused acute myocardial infarction

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL OCCLUSION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HEART LEFT VENTRICLE; HEART MUSCLE REPERFUSION; IMAGE ANALYSIS; MEASUREMENT; MICROVASCULATURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPERFUSION;

ANIMALS; CONTRAST MEDIA; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; GADOLINIUM DTPA; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MICROCIRCULATION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; SWINE; TIME FACTORS;

EID: 37349016239     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21063     Document Type: Article

References (44)

1. Krug A, de Rochemont DM, Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res 1966;19:57-62.
2. Kloner RA, Ganote CE, Jennings RB, et al. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-1508.
3. Camilleri JP, Joseph D, Fabiani JN, et al. Microcirculatory changes following early reperfusion in experimental myocardial infarction. Virchows Arch A Pathol Anat Histol 1976;369:315-333.
4. Wu KC, Zehrhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998:97:765-772.
5. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005;26:549-557.
6. Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000;36:1202-1209.
7. Gerber BL, Rochitte CE, Melin JA, et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 2000;101:2734-2741.
8. Kramer CM. The prognostic significance of microvascular obstruction after myocardial infarction as defined by cardiovascular magnetic resonance. Eur Heart J 2005;26:532-533.
9. Reffelmann TR, Hale SL, Dow JS, Kloner RA. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation 2003;108:2911-2917.
10. Eeckhout E, Kern MJ. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J 2001;22:729-739.
11. Schwartz RS. Microvascular obstruction in acute coronary syndromes: onward to a new therapeutic target. Catheter Cardiovasc Interv 2005;66:170-172.
12. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101:570-580.
13. Kaul S, Ito H. Microvasculature in acute myocardial ischemia: part II: evolving concepts in pathophysiology, diagnosis, and treatment. Circulation 2004;109:310-315.
14. Jeremy RW, Links JM, Becker LC. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. J Am Coll Cardiol 1990;16:695-704.
15. Wu KC, Kim RJ, Bluemke DA, et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol 1998;32:1756-1764.
16. Choi CJ, Haji-Momenian S, DiMaria JM, et al. Infarct involution and improved function during healing of acute myocardial infarction: the role of microvascular obstruction. J Cardiovasc Magn Reson 2004;6:915-923.
17. Rochitte CE, Lima JA, Bluemke DA, et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998;98:1006-1014.
18. Schwitter J, Saeed M, Wendland MF, et al. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol 1997;30:1086-1094.
19. Krombach GA, Higgins CB, Chujo M, Saeed M. Gadomer-enhanced MR imaging in the detection of microvascular obstruction: alleviation with nicorandil therapy. Radiology 2005;236:510-518.
20. Wright GA, Brittain JH, Stainsby JA. In: Proceedings of the 4th Annual Meeting of ISMRM, New York, NY, USA, 1996 (Abstract 1474).
21. Foltz W, Huang H, Fort S, Wright G. Vasodilator response assessment in porcine myocardium with magnetic resonance relaxometry. Circulation 2002;106:2714-2719.
22. Thornhill RE, Prato FS, Wisenberg G, Moran GR, Sykes J. Determining the extent to which delayed-enhancement images reflect the partition-coefficient of Gd-DTPA in canine studies of reperfused and unreperfused myocardial infarction. Magn Reson Med 2004;52:1069-1079.
23. Kay I, Henkelman RM. Practical implementation and optimization of one-shot T1 imaging. Magn Reson Med 1991;22:414-424.
24. Bjornerud A, Johansson LO, Briley-Saebo KB, Ahlstrom HK. Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state - dependence on blood volume and water exchange. Magn Reson Med 2002;47:461-471.
25. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228.
26. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002;39:591-597.
27. Resnic FS, Wainstein M, Lee MK, et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J 2003;145:42-46.
28. Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 2001;38:659-665.
29. Reffelmann T, Hale SL, Li G, Kloner RA. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol 2002;282:H766-H772.
30. Tarantini G, Cacciavillani L, Corbetti F, et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol 2005;46:1229-1235.
31. Koyama Y, Matsuoka H, Mochizuki T, et al. Assessment of reperfused acute myocardial infarction with two-phase contrast-enhanced helical CT: prediction of left ventricular function and wall thickness. Radiology 2005;235:804-811.
32. Lardo AC, Cordeiro MA, Silva C, et al. Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation 2006;113:394-404.
33. Higgins CB, Herfkens R, Lipton M, et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol 1983;52:184-188.
34. Wisenberg G, Prato F, Carroll S, Turner K, Marshall T. Serial nuclear magnetic resonance imaging of acute myocardial infarction with and without reperfusion. Am Heart J 1988;115:510-518.
35. McNamara MT, Tscholakoff D, Revel D, et al. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology 1986;158:765-769.
36. Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG. T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2003;5:353-359.
37. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656-662.
38. Regan TJ, Broisman L, Haider B, Eaddy C, Oldewurtel HA. Dissociation of myocardial sodium and potassium alterations in mild versus severe ischemia. Am J Physiol 1980;238:H575-H580.
39. Rochitte CE, Kim RJ, Hillenbrand HB, Chen EL, Lima JA. Microvascular integrity and the time course of myocardial sodium accumulation after acute infarction. Circ Res 2000;87:648-655.
40. Lotan C, Miller S, Cranney G, Pohost G, Elgavish G. The effect of postinfarction intramyocardial hemorrhage on transverse relaxation time. Magn Reson Med 1992;23:346-355.
41. Lotan C, Bouchard A, Cranney G, Bishop S, Pohost G. Assessment of postreperfusion myocardial hemorrhage using proton NMR imaging at 1.5T. Circulation 1992;86:1018-1025.
42. Ochiai K, Shimada T, Murakami Y, et al. Hemorrhagic myocardial infarction after coronary reperfusion detected in vivo by magnetic resonance imaging in humans: prevalence and clinical implications. J Cardiovasc Magn Reson 1999;1:247-256.
43. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92:1902-1910.
44. Flacke SJ, Fischer SE, Lorenz CH. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology 2001;218:703-710.